WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 9001 Infant (under 12 months) mortality rate: 332
GDP / capita (US$): 2'5571 Child (under 5 years) mortality rate: 412

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 156'595  154'695  152'862  151'125  149'503  132'383  107'386  82'498 
Births 3'138  3'150  3'161  3'174  3'193  3'576  3'768  3'560 
Surviving infants 3'039  3'045  3'049  3'055  3'065  3'353  3'406  3'098 
Pop. less than 5 years 15'128  15'074  15'118  15'309  15'474  16'731  16'553  14'325 
Pop. less than 15 years 46'977  47'197  47'475  47'852  48'103  48'951  45'160  36'594 
Female 15-49 years 43'874  43'170  42'427  41'634  40'848  32'645  24'027  17'546 

Number of reported case

(Click for retrospective incidence data for Bangladesh)
Diphtheria 16  11  27  23  21  711  1'559 
Japanese encephalitis 23  52  103  15  15 
Measles 237  1'986  5'625  788  718  5'098  1'705  11'077 
Mumps
Pertussis 13  44  17  16  252  4'879  12'436 
Polio* 198  374  65 
Rubella 3'034  3'245  5'631  12'963  13'076 
Rubella (CRS) 19 
Tetanus (neonatal) 108  109  98  117  121  376  740  1'068 
Tetanus (total) 508  614  644  710  791  1'155  2'511  2'855 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bangladesh)
Vaccine year result method % card seen                                                
BCG          99  99  99  99  99  95  91 
DTP1          91  99  99  99  99  88 
DTP3          92  90  90  89  87  68  69 
HepB_BD         
HepB3          92  90  90  89  87 
Hib3          92  90  90  95  87 
JapEnc         
MCV          89  89  86  89  88  61  82 
MCV2          99  22 
PCV1         
PCV3         
Pol3          92  95  95  94  94  68  69 
Rota1         
Rota_last         
Rubella1          89  17 
TT2plus 2010  42  DHS   67  96  96  96  95  95  89  73 
PAB         
VAD1          84  92  85  93  82  68 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bangladesh)
BCG 99  99  99  98  99  94  86 
DTP1 99  99  99  98  99  92  86 
DTP3 97  97  96  94  97  82  69 
HepB3 97  97  96  94  97 
HepB_BD
Hib3 97  97  96  94  97 
MCV 93  93  91  88  93  74  65 
MCV2 81  22 
PAB 94  94  94  93  93  89  70 
PnC3
Pol3 97  97  96  94  97  83  69 
Rota_last

Number of districts in the country 64  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 11
From 50 to 79% 2
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
MR 38 weeks; 15 years Yes dose at Y15 is for women only
Measles 15 Months; Yes
OPV 6, 10, 14, 38 weeks; Yes
TT 15 years; +1, +6 months; +1, +1 year; Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2011-2016  2011-2016  2008-2010  2008-2010  2008-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 64  70  64  64  64  64  64 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 64  64  64  64  64  64  64 
Nº districts with DTP3 coverage >=80% number 63  51  51  51  51  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 98  80  80  80  80  17 
Nº districts with measles (MCV1) coverage >=95% number 49  54  26  28  35  35   
% of districts with MCV1 coverage >=95% From 0 to 100% 77  84  41  44  55  55   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 30  37  30  29  30  85  60 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.